Nest.Bio Ventures is a venture capital and private equity firm investing in life science companies that is headquartered in Boston, Massachusetts and was founded in 2016 by Cheryl Cui, Hingge Hsu, James Weis, and Daphene Teo.
Notable investments made by Nest.Bio Ventures include: Engine Biosciences, HiFiBio Therapeutics, ResTORbio, and Root Path.
Nest.Bio Labs is a business accelerator with over 40,000 square feet of laboratory and office space in the United States and Singapore for incubating biotechnology companies. Lab equipment available at Nest.Bio Labs include: thermocycler, qRT-PCR, plate washer and reader, light and UV microscopes, imaging stations, water purification systems, fume hoods, autoclaves, a cell culture room with biosafety cabinets and incubators, centrifuge, bottle wash, water baths, fridges, freezers, ice machines, and vacuum and nitrogen supplies at every lab bench.
Notable graduates and residents of Nest.Bio Labs are Beam Therapeutics, BioBot Analytics, Act Nano, Mother Dirt, Platelet Biogenesis, HiFiBio Therapeutics, Savran Technologies Inc., CuraCloud, Phast, FOUNT Bio, Glydebio, and Geode Therapetuics.
A synthetic biology company that designs, builds and tests genetic circuits for the purposes programming cell therapies. Their first therapeutic candidates are aimed at solid tumors and blood cancer and the company plans to move beyond oncology.
A biopharmaceutical company developing therapeutics for treating age-related diseases.
A biotechnology company in Massachusetts that focuses on developing technology to produce donor-independent human platelets from human induced pluripotent stem cells.
POINTS is the first truly scalable blockchain data collaboration protocol